Previous 10 | Next 10 |
Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations Mr. Caravella’s appointment demonstrates Medicenna’s continuing commitment to establish its presence in Boston, ...
2023-08-17 05:05:00 ET On Aug. 7, Tango Therapeutics (NASDAQ: TNGX) reported its second-quarter earnings, and by Aug. 11, its shares were up by a shocking 126%. Its earnings update didn't make any waves; this is a pre-revenue biotech company, and it didn't report any stunningly posi...
2023-08-14 08:32:23 ET AMC Entertainment Holdings ( AMC ) -33% . BioXcel Therapeutics BTAI -32% after Q2 earning release . Bridgeline Digital BLIN -19% after Q3 earning release . Black Spade Acquisition Co ( BSAQ ) -16% . Fortrea Holdings FT...
2023-08-10 16:52:14 ET Shares of Tango Therapeutics (NASDAQ: TNGX) were up more than 91% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed last week at $3.40 and reached a...
2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...
2023-08-10 07:30:00 ET Summary Tango Therapeutics is advancing in cancer treatment with Phase 1/2 clinical trials for TNG908 and TNG462, targeting MTAP-deleted tumors. Tango's stock soared by over 100% following Mirati's announcement on their unique PRMT5 inhibitor, emphasizing po...
2023-08-10 07:24:00 ET Clinical-stage biotechnology Tango Therapeutics ( NASDAQ: TNGX ) down 15% as the company will sell ~15.5M shares at a per share price of $5.15. The financing is expected to close on Friday, August 11, 2023. Gross proceeds from the private pla...
BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, has agreed to sell approximately 15.5 million shares of its common stock (“Co...
2023-08-09 13:27:46 ET Gainers: Benitec Biopharma ( BNTC ) +81% . Tango Therapeutics ( TNGX ) +77% . Decibel Therapeutics ( DBTX ) +76% . T Stamp ( IDAI ) +50% . Millennium Group International Holdings ( MGIH ) +43% . EBET ( ...
2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...
News, Short Squeeze, Breakout and More Instantly...
Tango Therapeutics Inc. Company Name:
TNGX Stock Symbol:
NASDAQ Market:
2024-06-25 02:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present...